Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer. The company is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with thepotential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent.Elevar Therapeutics holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.

Biotechnology

Design

Health Care

Pharmaceutical

Therapeutics

Elevar Therapeutics

Elevar Therapeutics' headquarters in Salt Lake City, UT, United States

Kenny Rankin

Laura Alexander M.D., M.S.

Fahima Munir

Michael Palucki

Darren Brayton

Xiaohui Wei

Heather Lane

Thomas Sanford, MBA

Sunam Tiwari, MBA

Mike Young

Deanna Giglio

The Leadership Team at Elevar Therapeutics is responsible for guiding the strategic direction and overall operations of the company. This cross-functional team, composed of executives from key areas such as quality, manufacturing, clinical data management, legal, finance, and human resources, collaborates to ensure the successful development and commercialization of innovative cancer therapies while addressing regulatory requirements and market needs. Their leadership fosters a culture of excellence and drives the mission to meet unmet medical needs in oncology.

Leadership Team

The Clinical Data Management Team at Elevar Therapeutics is responsible for overseeing the collection, management, and quality assurance of clinical trial data. This team ensures that all data generated during the trials for their proprietary drug candidates is accurate, compliant with regulatory standards, and ready for analysis. By employing robust data management practices, they play a crucial role in supporting the company's efforts to bring effective cancer therapies to market.

Clinical Data Management Team

The Finance and Accounting team at Elevar Therapeutics is responsible for managing the company's financial planning, budgeting, and reporting processes to ensure fiscal health and compliance. This team plays a critical role in tracking expenses and revenue related to the development of innovative cancer therapies, providing insights for strategic decision-making, and supporting financial operations that align with the company's mission to address unmet medical needs.

Finance and Accounting

The Medical Affairs Team at Elevar Therapeutics plays a crucial role in bridging clinical research and commercial activities by providing scientific expertise and support for the development of innovative cancer therapies. This team collaborates closely with healthcare professionals to communicate the clinical value of the company’s drug candidates, oversees the planning and execution of medical education programs, and ensures compliance with regulatory standards. Through evidence generation and stakeholder engagement, they enhance the understanding of products and contribute to advancing patient care in oncology.

Medical Affairs Team

The Quality Assurance and Compliance team at Elevar Therapeutics is responsible for ensuring that all pharmaceutical products meet regulatory standards and internal quality benchmarks. This team oversees the development and implementation of quality management systems, conducts audits, and manages compliance with FDA regulations and international guidelines. They play a critical role in safeguarding patient safety through rigorous pharmacovigilance practices and by ensuring that all operational processes align with industry regulations.

Elevar Therapeutics

Org chart

Teams

Leadership Team

Clinical Data Management Team

Finance and Accounting

Medical Affairs Team

Quality Assurance and Compliance

Offices

Elevar Therapeutics

Org chart

Teams

Leadership Team

Clinical Data Management Team

Finance and Accounting

Medical Affairs Team

Quality Assurance and Compliance

Offices

Related companies